Medical Weight Loss
Semaglutide: Beyond Diabetes Management
​
While Semaglutide gained initial recognition for its role in managing type 2 diabetes, its recent FDA approval for weight loss has opened up new possibilities for those seeking effective and sustainable solutions to shed unwanted pounds. Semaglutide belongs to the GLP-1 receptor agonist class, known for its impact on appetite control and metabolism. Through extensive clinical studies, Semaglutide has demonstrated its efficacy in addressing not only diabetes but also in promoting significant and sustained weight loss.
​
FDA Approval for Weight Loss
​
Semaglutide's approval by the Food and Drug Administration (FDA) for weight loss is a groundbreaking development. Rigorous clinical trials have demonstrated its capacity to not only regulate blood sugar levels but also to induce significant weight loss. This dual action makes Semaglutide a versatile and promising option for individuals aiming to address both diabetes and obesity.
How the program works
Step 1
​
Schedule an in-person consultation with our medical provider. Discuss goals, lifestyle, diet and other family history or medical conditions. Have our baseline body measurement taken.
Step 2
​
Get medication and weight loss injection with a personalized plan to start losing weight. Schedule your weekly appointment. Commitment for program duration is required.
Step 3
​
Start losing weight! Continue weekly office visit with our medical provider to discuss results, changes to diet, and medical conditions. Monitor your progress towards your goal!
Semaglutide: The Science Behind Weight Loss
Semaglutide belongs to the GLP-1 receptor agonist class, known for its impact on appetite control and metabolism. Through extensive clinical studies, Semaglutide has demonstrated its efficacy in addressing not only diabetes but also in promoting significant and sustained weight loss.
​
Clinical Study Data
​
1. Semaglutide and Weight Loss: A Comprehensive Analysis
In a groundbreaking clinical trial involving thousands of participants, Semaglutide showcased remarkable weight loss results. Participants experienced a substantial reduction in body weight, with a majority achieving and maintaining clinically significant weight loss over an extended period.
​
2. Appetite Suppression and Satiety Enhancement
​
Semaglutide's ability to activate the GLP-1 receptor has been proven to effectively control appetite. Participants reported feeling more satisfied with smaller meals, leading to a reduction in overall calorie intake and facilitating a steady and sustainable weight loss.
Precautions / Side Effects
As with any medication, semaglutide may cause side effects. Common reactions include gastrointestinal issues such as nausea, vomiting, diarrhea, abdominal pain and constipation. Some individuals may experience more severe side effects, such as pancreatic inflammation, changes in vision or low blood sugar when used with other diabetes medications. It is not suitable for use in people with type 1 diabetes or diabetic ketoacidosis. Additionally, it is not approved for anyone under 18 years old. It is crucial to discuss all potential risks with a healthcare provider before starting treatment with semaglutide